The battle for Illumina continues.
The genetic analysis services provider said that Roche’s $5.7 billion takeover offer was “grossly inadequate” and that the Swiss drug maker’s director candidates should be rejected.
About
About us: We are three biostatistics professors (Jeff Leek, Roger Peng, and Rafa Irizarry) who are fired up about the new era where data are abundant and statisticians are scientists.
Follow us: Follow @simplystats
About this blog: We’ll be posting ideas we find interesting, contributing to discussion of science/popular writing, linking to articles that inspire us, and sharing advice with up-and-coming statisticians.
Why “Simply Statistics”: We needed a title. Plus, we like the idea of using simple statistics to solve real, important problems. We aren’t fans of unnecessary complication - that just leads to lies, damn lies and something else.
